CLINICAL_TRIALS
other
· 2026-01-14
Clinical Trial Update: Helping Ovarian Cancer Patients Cope With Their Illness (HOPE) [NA]
Summary
The HOPE trial for recurrent ovarian carcinoma has been suspended.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Fred Hutchinson Cancer Center | Conditions: Recurrent Ovarian Carcinoma | NA | Status: SUSPENDED